# Exercise Intervention for Pts With Metastatic Castration-Resistant Prostate Cancer Receiving Abiraterone or Enzalutamide

> **NCT02130947** · NA · WITHDRAWN · sponsor: **UNC Lineberger Comprehensive Cancer Center**

## Conditions studied

- Metastatic Castration Resistant Prostate Cancer (mCRPC)

## Interventions

- **BEHAVIORAL:** Exercise

## Key facts

- **NCT ID:** NCT02130947
- **Lead sponsor:** UNC Lineberger Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-04
- **Primary completion:** 2016-02
- **Final completion:** 2016-02
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** We were not able to accrue any participants.
- **Last updated:** 2016-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02130947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02130947, "Exercise Intervention for Pts With Metastatic Castration-Resistant Prostate Cancer Receiving Abiraterone or Enzalutamide". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02130947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*